SS
IART icon

SBI Securities’s Integra LifeSciences IART Stock Holding History

SBI Securities’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.62K Buy
+1,021
New +$11.2K ﹤0.01% 1735
2025
Q4 		– Sell
-2
Closed -$29 – 4123
2025
Q3 		$29 Sell
2
-1
-33% -$14 ﹤0.01% 3842
2025
Q2 		$37 Sell
3
-10
-77% -$145 ﹤0.01% 3784
2025
Q1 		$286 Buy
13
+3
+30% +$71 ﹤0.01% 3086
2024
Q4 		$227 Buy
+10
New +$218 ﹤0.01% 3192

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SBI Securities's IART Position: Q1 2026 in Review

SBI Securities opened a new position in Integra LifeSciences (IART) in Q1 2026: 1,021 shares worth $9.62K. The stake represents ﹤0.01% of the portfolio and ranks #1735 among its holdings. This is a return to the name: SBI Securities previously reported a position in IART as recently as Q3 2025.

SBI Securities first reported a position in IART in Q4 2024 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • SBI Securities held 1,021 shares of Integra LifeSciences worth $9.62K as of Q1 2026.
  • Integra LifeSciences was a new SBI Securities position in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1735 holding.
  • SBI Securities first reported a position in Integra LifeSciences in Q4 2024 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.